BrosMed Medical Announces CE Mark and Launch of Wedge™ Semi-complaint Scoring PTCA
October 27th, 2017—BrosMed Medical announced CE Mark and Launched its Wedge™ Scoring PTCA Balloon for the treatment of percutaneous transluminal coronary angioplasty (PTCA) for the purpose of improving myocardial blood flow in the localized stenotic lesion of the coronary arteries.
As apart of BrosMed Medical balloon catheter portfolio, Wedge™ Semi-complaint Scoring PTCA balloon is designed to satisify clinical needs which current cutting/scoring PTCA not met. The aim of Wedge™ Semi-Compliant Scoring PTCA balloon would be simply treated as workhorse PTCA for small/difussed/calcified lesion which would maximally eliminate dissection with minimal slippage phenomena. With smallest 1.5mm balloon diameter available, up to 30mm balloon length and comprehensive configurations including quarter sizes will provide more choices while current scoring not.
According to the company, Wedge™ is rapid exchange PTCA balloon catheter which required limited training to the physicians and it will not alter physicians’ current practice and Wedge™ PTCA would be used like conventional PTCA. Constructed with engineered material, the Wedge™ Semi-complaint Scoring PTCA catheter has consistent rated burst pressures of 14atm from φ1.5 to φ4.0mm.
“We believe that the launch of Wedge™ Scoring PTCA will be game change to the current scoring PTCA market due to its unique design gained from first-hand physicians’ experiences.It is simple and exffective for physicians’ daily work and would reduce the hesitation of using scoring PTCA due to its crossability.” said by Stephen Lee, General Manager of BrosMed Medical.
“The launch of Wedge™ Scoring PTCA will definaltely differentiate ourselves to others and enhance BrosMed brand in the market. Beside our excellent Artimes™ and Apollo™ NC PTCA, we got new products entering the market and we believe it will be again reputed.” said by Jos A.W.J de Korte, General Manager of BrosMed Medical B.V., the Netherlands, marketing and sales center of BrosMed Medical in Europe.
About BrosMed Medical
BrosMed Medical is more than just a company; we are leading the medical device design and manufacturing revolution.
BrosMed Medical develops, manufactures and markets medical devices primarily used by interventional cardiologists, radiologists and vascular surgeons in angioplasty procedures and other minimal invasive devices.
We provide solutions to our customers through innovative design, effective supply chain management, world-class manufacturing, and flexible channels of distribution and through the development or acquisition of innovative technologies.
BrosMed Medical product portfolio consist of, Artimes™ PTCA, Apollo™ NC PTCA, Wedge™ Semi-complaint Scoring PTCA, Atropos™ 0.035 PTA, Minerva™ 0.018 PTA, Polux™ 0.014 PTA, Hermes™ NC 0.035 PTA, Achilles™ NC 0.018 PTA, Castor™ NC 0.014 PTA, Conger™ Hydrophilic coated guidewire and Freepath™ Catheter Sheath Introducer. BrosMed Medical is supplying safe, effective and hi-tech medical devices in 30 countries.